SILO PHARMA, INC. Management And Service Fees Base Rate
SILO PHARMA, INC. (SILO) reported Management And Service Fees Base Rate of 1.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:ManagementAndServiceFeesBaseRate · last filed 2026-08-13
- SILO PHARMA, INC. management and service fees base rate for the quarter ending 2026-03-31 was 1.00%.
| Period end | Management And Service Fees Base Rate 3 month | Management And Service Fees Base Rate 6 month | Management And Service Fees Base Rate 9 month | Management And Service Fees Base Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00% 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 1.00% 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 1.00% POS AM · filed 2026-04-14 | |||
| 2025-09-30 | 1.00% 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 1.00% 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |